GSK503
GSK-503 is a potent and selective small molecule inhibitor of EZH2, demonstrating antitumor activity in preclinical studies. It is widely used in epigenetic research to investigate histone methylation's role in cancer, with applications in both in vitro cellular assays and in vivo animal models for oncology.
Product Specifications
CAS Number
1346572-63-1
Product Name Alternative
Inhibit, Histone Methyltransferase, HistoneMethyltransferase, Inhibitor, EZH2, GSK503, GSK-503, GSK 503
Field of Research
Epigenetics & Chromatin
Purity
98.00% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (6.27 mM) ; DMSO:93 mg/mL (176.58 mM) ; H2O:< 1 mg/mL (insoluble or slightly soluble) ; Ethanol:25 mg/mL (47.47 mM)
Smiles
CC (C) n1cc (C) c2c (cc (cc12) -c1ccc (nc1) N1CCN (C) CC1) C (=O) NCc1c (C) cc (C) [nH]c1=O
Molecular Formula
C31H38N6O2
Molecular Weight
526.67
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C2390-03 100 µg
CD38 (Acute Lymphoblastic Leukemia Cells Antigen, ADP Ribosyl Cyclase, CADPr Hydrolase 1, Cyclic ADP Ribose Hydrolase, Ecto Nicotinamide Adenine Dinucleotide Glycohydrolase, I19 (Mouse), Lymphocyte Differentiation Antigen) discontinued, see C2390-05T
Sign In for Pricing
View Details S1014-20B-AP 100 µL
SLP-76 (lymphocyte cytosolic protein 2, SH2 domain containing leukocyte protein of 76kD, Lymphocyte cytosolic protein 2, SH2 domain-containing leukocyte protein of 76kD, SLP76, SLP-76 tyrosine phosphoprotein) (AP) discontinued
Sign In for Pricing
View Details